Medication info
Hyundai Minoxidil Tablet

Hyundai Minoxidil Tablet

Prescription medicationTabletOral
Ingredient · strength
Minoxidil›5mg / 1 tablet
Manufacturer / importer
Hyundai Pharmaceutical Co., Ltd.
Appearance
It is a white round tablet.
Packaging
30 tablets/bottle, 90 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 198501401 · Notified 1985.07.11 · Insurance code 642001290

Summary

Main use
Treatment of resistant hypertension and hypertension with symptoms or target-organ damage
Who takes it
Adults · Children
Adult dose
Adults (12 years and older): The initial dose is 5㎎ of minoxidil orally once daily, and the maintenance dose is 10-40㎎ per day in 1 to several divided doses. Up to 100㎎ per day may be administered. Frequency of administration: During treatment with this medication, the magnitude of daily fluctuations in arterial blood pressure is proportional to the amount of blood pressure reduction. If the reduction in diastolic blood pressure is less than 30mmHg, the medication may be administered once daily; if it is 30mmHg or greater, administer it in 2 divided doses daily. Dose adjustment: The dose should be determined carefully according to the patient's response. When adjusting the dose, allow an interval of at least 3 days, as an adequate response to the dose may take 3 days or more to appear. If more rapid treatment of hypertension is required, the dose may be adjusted every 6 hours while carefully monitoring the patient. Concomitant administration 1) Diuretics: This medication is administered concomitantly with a diuretic in patients who depend on renal function to maintain salt and water balance. It has been used in combination with the following diuretics. ① Hydrochlorothiazide (50㎎ per dose twice daily) or another thiazide diuretic (equivalent effective dose) ② Chlorthalidone (50-100㎎ per dose once daily) ③ Furosemide (40㎎ per dose twice daily) If excessive salt and water retention results in a weight gain of approximately 1.8㎏ or more, the diuretic should be changed to furosemide; if the patient is already receiving furosemide, increase the dose as necessary. 2) β-blockers or other sympatholytic agents: During administration of this medication, administer a β-blocker in divided doses equivalent to 80-160㎎ of propranolol per day. If β-blockers are contraindicated, methyldopa (250-750㎎ per dose twice daily) may be administered instead. Since methyldopa takes time to exert its effect, administer it at least 24 hours before starting this medication. Sympatholytic agents may not completely block the increase in heart rate caused by this medication, but they can generally prevent tachycardia. Patients receiving a β-blocker before initiation of treatment with this medication typically have bradycardia; however, the heart rate is expected to increase to normal when this medication is administered. When this medication is administered concomitantly with a β-blocker or another sympatholytic agent, the opposing effects on the heart counterbalance each other, resulting in little change in heart rate. Adjust the dose as appropriate according to age and symptoms.
Child dose
Children (12 years and younger): The initial dose is 0.2㎎ per kg of body weight once daily. The dose may be increased by 50-100% until blood pressure is optimally controlled. The maintenance dose is 0.25㎎-1.0㎎ per kg of body weight per day. Up to 50㎎ per day may be administered.

Ingredients

Manufacturer
Hyundai Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of resistant hypertension and hypertension with symptoms or target-organ damage

  • Symptomatic hypertension
  • hypertension due to target organ damage
  • resistant hypertension
View approved original text

This medication is used for patients with symptomatic hypertension or hypertension due to specific organ damage. It is also effective in treating resistant hypertension that is uncontrolled even after taking diuretics and two types of antihypertensive agents at maximum doses. Therefore, this medication is used for the treatment of various forms of difficult hypertension.

How to take

Adult dose

Adults (12 years and older): The initial dose is 5㎎ of minoxidil orally once daily, and the maintenance dose is 10-40㎎ per day in 1 to several divided doses. Up to 100㎎ per day may be administered. Frequency of administration: During treatment with this medication, the magnitude of daily fluctuations in arterial blood pressure is proportional to the amount of blood pressure reduction. If the reduction in diastolic blood pressure is less than 30mmHg, the medication may be administered once daily; if it is 30mmHg or greater, administer it in 2 divided doses daily. Dose adjustment: The dose should be determined carefully according to the patient's response. When adjusting the dose, allow an interval of at least 3 days, as an adequate response to the dose may take 3 days or more to appear. If more rapid treatment of hypertension is required, the dose may be adjusted every 6 hours while carefully monitoring the patient. Concomitant administration 1) Diuretics: This medication is administered concomitantly with a diuretic in patients who depend on renal function to maintain salt and water balance. It has been used in combination with the following diuretics. ① Hydrochlorothiazide (50㎎ per dose twice daily) or another thiazide diuretic (equivalent effective dose) ② Chlorthalidone (50-100㎎ per dose once daily) ③ Furosemide (40㎎ per dose twice daily) If excessive salt and water retention results in a weight gain of approximately 1.8㎏ or more, the diuretic should be changed to furosemide; if the patient is already receiving furosemide, increase the dose as necessary. 2) β-blockers or other sympatholytic agents: During administration of this medication, administer a β-blocker in divided doses equivalent to 80-160㎎ of propranolol per day. If β-blockers are contraindicated, methyldopa (250-750㎎ per dose twice daily) may be administered instead. Since methyldopa takes time to exert its effect, administer it at least 24 hours before starting this medication. Sympatholytic agents may not completely block the increase in heart rate caused by this medication, but they can generally prevent tachycardia. Patients receiving a β-blocker before initiation of treatment with this medication typically have bradycardia; however, the heart rate is expected to increase to normal when this medication is administered. When this medication is administered concomitantly with a β-blocker or another sympatholytic agent, the opposing effects on the heart counterbalance each other, resulting in little change in heart rate. Adjust the dose as appropriate according to age and symptoms.

Child dose

Children (12 years and younger): The initial dose is 0.2㎎ per kg of body weight once daily. The dose may be increased by 50-100% until blood pressure is optimally controlled. The maintenance dose is 0.25㎎-1.0㎎ per kg of body weight per day. Up to 50㎎ per day may be administered.

Precautions

This medication should not be used in certain patients. For example, in patients with pheochromocytoma, this medication can lower blood pressure while promoting catecholamine secretion from tumors, so it should not be administered. Also, patients with pulmonary hypertension due to mitral stenosis, acute myocardial infarction, and those allergic to this medication should avoid usage. In patients with chronic congestive heart failure, severe renal failure, and angina, this medication should be administered cautiously, always considering the possibility of side effects. Using this medication may cause hirsutism, which typically starts on the face and body, and it gradually returns to the original state upon stopping the medication. An allergic reaction may cause rashes or blisters on the skin, so attention to skin changes is necessary. Blood tests may show a decrease in platelet and white blood cell counts, and certain enzyme levels may rise without liver or bone marrow dysfunction. Changes in T-wave on electrocardiogram are common but usually disappear with continued treatment and do not cause significant heart issues. Rarely, symptoms such as pericardial effusion or fluid accumulation around the heart may occur, so careful observation of the heart condition is essential. Additionally, side effects such as weight gain, peripheral edema, increased heart rate, gastrointestinal disturbances, rashes, and breast pain may occur rarely. When using this medication, diuretics are often used together to prevent fluid retention and heart failure, and regular checks of weight and electrolyte status are necessary. Due to its vasodilatory effect, fast heart rates or angina symptoms may occur, and beta-blockers may be administered concurrently to prevent this. Patients with renal failure or dialysis may require reduced medication doses, so renal function must be managed carefully. Myocardial infarction patients should only receive this medication after the condition has stabilized, and routine checks of urinalysis, renal function tests, electrocardiograms, and chest X-rays should be performed regularly at the initial administration. This medication can interact with other drugs; taking it with guanethidine may cause severe hypotension, so co-administration should be avoided or initiated under hospitalization. Antidepressants or antipsychotics may increase the risk of hypotension with this medication, and caution is needed when used with corticosteroids or certain anti-inflammatory analgesics, as they may affect fluid retention or blood pressure control. Safety has not been established during pregnancy, so use should be avoided, and during breastfeeding, it is advisable to either discontinue breastfeeding or avoid administration as it may be transmitted into breast milk. Experience in children, especially newborns, is limited, so it should be administered with caution. In case of overdose, there may be severe hypotension, so immediately consult medical personnel and receive appropriate treatment, and sympathomimetics should be avoided.

Side effects

Hair growth, thickening, pigmentation increase, exudative rash, vesicular lesions, mucocutaneous syndrome, thrombocytopenia, leukopenia, decreased hematocrit, decreased hemoglobin, decreased red blood cells, increased ALP, changes in the direction and amplitude of the ECG T wave, pericardial effusion, ischemia, weight gain, peripheral vascular edema, increased heart rate, elevated creatinine, elevated BUN, gastrointestinal disturbances, rash, breast pain, gynecomastia, hemolytic anemia, pulmonary infiltrates, increased antinuclear antibodies, headache, intermittent claudication, frequent menstruation, nausea, vomiting

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is also advisable to keep it away from direct sunlight and store it at room temperature.

Appearance and packaging

Appearance

It is a white round tablet.

Package unit

30 tablets/bottle, 90 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.